Costs of schizophrenia

British Journal of Psychiatry

Volumn 171, Issue DEC., 1997, Pages 509-518

  Knapp, Martin ^a,b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

COMMUNITY MENTAL HEALTH; COST EFFECTIVENESS ANALYSIS; CRIMINAL JUSTICE; DRUG COST; HEALTH CARE COST; HOSPITALIZATION; HUMAN; PATIENT COMPLIANCE; PSYCHOTHERAPY; QUALITY OF LIFE; RELAPSE; REVIEW; SCHIZOPHRENIA; SOCIAL WELFARE; UNITED KINGDOM;

EID: 0030719980     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.171.6.509     Document Type: Review

References (117)

1. Addington, D. E., Jones, B., Bloom, D., et al (1993) Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study. Clinical Therapeutics, 15, 917-926.
2. Aitchison, K. J. & Kerwin, R. W. (1997) The cost-effectiveness of clozapine: a UK clinic-based study. British Journal of Psychiatry, 171, 125-130.
3. Albright, P. S., Livingstone, S., Keegan, D. L., et al (1996) Reduction of health care resource utilisation and costs following the use of risperidone for patients with schizophrenia previously treated with standard antipsychotic therapy. Clinical Pharmacoeconomics, 11, 289-299.
4. Allebeck, P. (1989) Schizophrenia: a life-shortening disease. Schizophrenia Bulletin, 15, 81-89.
5. Anderson, C., Connelly, J., Johnstone, E. C., et al (1991) Disabilities and circumstances of schizophrenic patients: V. Cause of death. British Journal of Psychiatry, 159 (suppl. 13), 30-33.
6. Andrews, G., Hall, W., Goldstein, G., et al (1985) The economic costs of schizophrenia. Archives of General Psychiatry, 42, 537-543.
7. Audini, B., Marks, I. M., Laurrence, R. E., et al (1994) Home-based versus out-patient/in-patient care for people with serious mental illness: phase II of a controlled trial. British Journal of Psychiatry, 165, 204-210.
8. Beecham, J. K., Knapp, M. R. J. & Allen, C. (1995) Comparative efficiency and equity in community-based care. In The Economic Evaluation of Mental Health Care (ed. M. R. J. Knapp), pp. 175-194. Aldershot: Arena.
9. _, Hallam, A., Knapp, M. R. J., et al (1997) Costing care in the hospital and in the community. In Care in the Community: Illusion or Reality? (ed. J. Leff), pp. 93-108. Chichester: Wiley.
10. Birmingham, L., Mason, D. & Grubin, D. (1996) Prevalence of mental disorder in remand prisoners: consecutive case study. British Medical Journal, 313, 1521-1524.
11. Black, D.W. & Fisher, R. (1992) Mortality in DSM-IIIR schizophrenia. Schizophrenia Research, 7, 109-116.
12. Boczkowski, J. A., Zeicher, A. & DeSanto, N. (1985) Neuroleptic compliance among chronic schizophrenic outpatients: An intervention outcome report. Journal of Consulting and Clinical Psychology, 53, 666-671.
13. Breier, A., Schreiber, J. L., Dyer, J., et al (1991) National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia. Archives of General Psychiatry, 48, 239-246.
14. Brooke, D., Taylor, C., Gunn, J., et al (1996) Point prevalence of mental disorder in unconvicted male prisoners in England and Wales. British Medical Journal, 313, 1524-1527.
15. Brooker, C. (1990) A description of clients nursed by CPNs. Journal of Advanced Nursing, 15, 155-166.
16. Buchanan, A. (1992) A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine, 22, 787-797.
17. Burns, T., Beardsmore, A., Bhat, A. V., et al (1993a) A controlled trial of home-based acute psychiatric services. I: Clinical and social outcome. British Journal of Psychiatry, 163, 49-54.
18. _, Rafter, J., Beardsmore, A., et al (1993b) A controlled trial of home-based psychiatric services. 2. Treatment patterns and costs. British Journal of Psychiatry, 163, 55-61.
19. Cardin, V. A., McGill, C. W. & Falloon, I. R. H. (1986) An economic analysis: costs, benefits and effectiveness. In Family Management of Schizophrenia (ed. I. R. H. Falloon). Baltimore, MD: Johns Hopkins University Press.
20. Carone, B. J., Harrow, M. & Westermeyer, J. F. (1991) Posthospital course and outcome in schizophrenia. Archives of General Psychiatry, 48, 247-253.
21. Carpenter, W. T., Conley, R. R., Buchanan, R. W., et al (1995) Patient response and resource management: another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827-832.
22. Chisholm, D., Knapp, M. R. J., Astin, J., et al (1997) The mental health residential care study: predicting costs from resident characteristics. British Journal of Psychiatry, 170, 37-42.
23. Creed, F., Mbaya, P., Lancashire, S., et al (1997) Cost effectiveness of day and in-patient psychiatric treatment: results of a randomised controlled trial. British Medical Journal, 314, 1381-1385.
24. Davies, L. M. & Drummond, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. British Journal of Psychiatry, 162, 38-42.
25. _ & _ (1994) Economics and schizophrenia: the real cost. British Journal of Psychiatry, 165 (suppl. 25), 18-21.
26. Davis, J. M., Kane, J. M., Marder, S. R., et al (1993) Dose response of prophylactic antipsychotics. Journal of Clinical Psychiatry, 54 (suppl.), 24-30.
27. Donnelly, M., McGilloway, S., Mays, N., et al (1994) Opening New Doors: An Evaluation of Community Care for People Discharged from Psychiatric and Mental Handicap Hospitals. London: HMSO.
28. Eaton, W. W. (1985) Epidemiology of schizophrenia. Epidemiologic Review, 7, 105-125.
29. _, Mortensen, P. B., Herrman, H., et al (1992) Long-term course of hospitalization for schizophrenia. Part II: change with passage of time. Schizophrenia Bulletin, 18, 229-239.
30. Endicott, J., Herz, M. & Gibbon, M. (1978) Brief versus standard hospitalization: the standard costs. American Journal of Psychiatry, 135, 707-712.
31. Evers, S. M. A. A. & Ament, A. J. H. A. (1995) Costs of schizophrenia in the Netherlands. Schizophrenia Bulletin, 21, 141-153.
32. Foster, K., Meltzer, H., Gill, B., et al (1996) Adults with a Psychotic Disorder Living in the Community, OPCS Surveys of Psychiatric Morbidity Report 8. London: HMSO.
33. Frances, A. & Weiden, P. (1987) Promoting compliance with outpatient drug treatment. Hospital and Community Psychiatry, 38, 1158-1160.
34. Frank, R. G. & Goldman, H. H. (1991) Clozapine's cost benefits (letters). Hospital and Community Psychiatry, 42, 92-93.
35. Gray, A., Marshall, M., Lockwood, A., et al (1997) Problems in conducting economic evaluations alongside clinical trials: lessons from a study of case management for people with mental disorders. British Journal of Psychiatry, 170, 47-52.
36. Guest, J. F., Hart, W. M., Cookson, R. F., et al (1996) Pharmacoeconomic evaluation of long-term treatment with risperidone for patients with chronic schizophrenia. British Journal of Medical Economics, 10, 59-67.
37. Gunderson, J. G. & Mosher, L. R. (1975) The cost of schizophrenia. American Journal of Psychiatry, 132, 901-906.
38. Hale, T. (1993) Will the new antipsychotics improve the treatment of schizophrenia? British Medical Journal, 307, 749-750.
39. Hogman, G. (1996) Is Cost a factor? London: National Schizophrenia Fellowship.
40. Honigfeld, G. & Patin, J. (1990) A two-year clinical and economic follow-up of patients on clozapine. Hospital and Community Psychiatry, 41, 882-885.
41. Hummer, M. & Fleischhacker, W. W. (1996) Compliance and outcome in patients treated with antipsychotics. The impact of extrapyramidal syndromes. CNS Drugs, 5 (suppl. I). 13-20.
42. Huxley, P. & Kerfoot, M. (1994) A survey of approved social work in England and Wales. British Journal of Social Work, 24, 311-324.
43. Hyde, C., Bridges, K., Goldberg, D., et al (1987) The evaluation of a hospital ward: a controlled study using modified cost-benefit analysis. British Journal of Psychiatry, 151, 805-812.
44. _ & Harrower-Wilson, C. (1995) Resource consumption in psychiatric intensive care: the cost of aggression. Psychiatric Bulletin, 19, 73-76.
45. Johnson, S., Ramsey, R., Thornicroft, G., et al (1997) London's Mental Health. London: King's Fund.
46. Johnstone, E. C., Frith, C. D., Leary, J., et al (1991) Background, method and general description of the sample. British Journal of Psychiatry, 159 (suppl. 13), 43-46.
47. Jönsson, D. & Wälinder, J. (1995) Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia. Acta Psychiatrica Scandinavica, 92, 199-201.
48. Kavanagh, S. & Opit, L. (1994) Estimating the Prevalence of Schizophrenia: A Model for Service Development. Discussion Paper 953. University of Kent at Canterbury: Personal Social Services Research Unit.
49. _, _, Knapp, M. R. J., et al (1995) Schizophrenia: shifting the balance of care. Social Psychiatry and Psychiatric Epidemiology, 30, 206-212.
50. Kemp, R. & David, A. (1996) Psychological predictors of insight and compliance in psychotic patients. British Journal of Psychiatry, 169, 444-450.
51. _, Hayward, P., Applewhaite, G., et al (1994) Compliance therapy in psychotic patients: randomized control trial. British Medical Journal, 312, 345-349.
52. Kendall, J. & Knapp, M. R. J. (1996) The Voluntary Sector in the UK. Manchester: Manchester University Press.
53. Kerwin, R.W. (1996) An essay on the new antipsychotics. Psychiatric Bulletin, 20, 23-29.
54. King, M. & Nazareth, I. (1996) Community care of patients with schizophrenia: the role of the primary care team. British Journal of General Practice, 46, 231-237.
55. Kissling, W. (ed.) (1991) Guidelines for Neuroleptic Relapse Prevention in Schizophrenia. Berlin: Springer Verlag.
56. _ & Fleischhacker, W. W. (1992) Optimising prophylactic treatment of schizophrenia by means of treatment standards and compliance improvement. Pharmacopsychiatry, 25, 69-71.
57. Knapp, M. R. J. (1997) Economics and mental health: a concise European history of demand and supply. In Making Mental Health Services Rational (ed M. Tanella), pp. 157-166. Roma: II Pensiero Scientifico.
58. _, Cambridge, P., Thomason, C., et al (1992) Care in the Community: Challenge and Demonstration. Aldershot: Avebury.
59. _, Beecham, J. K., Koutsogeorgopoulou, V., et al (1994) Service use and costs of home-based versus hospital-based care for people with serious mental illness. British Journal of Psychiatry, 165, 195-203.
60. _, _, Fenyo, A., et al (1995) Community mental health care for former hospital in-patients: predicting costs from needs and diagnoses. British Journal of Psychiatry, 166 (suppl. 27), 10-18.
61. _, Chisholm, D., Astin, J., et al (1997) The cost consequences of changing the hospital-community balance: the mental health residential care study. Psychological Medicine, 27, 681-692.
62. Kuipers, E. (1996) The management of difficult to treat patients with schizophrenia, using non-drug therapies. British Journal of Psychiatry, 169 (suppl. 31), 41-51.
63. Leff, J. P., Kuipers, E., Berkowitz, R., et al (1985) A controlled trial of intervention in the families of schizophrenic patients: two year follow-up. British Journal of Psychiatry, 146, 594-600.
64. _, Trieman, N. & Gooch, C. (1996) Prospective follow-up study of long-stay patients discharged from two psychiatric hospitals. American Journal of Psychiatry, 153, 1318-1324.
65. Lelliott, P., Audini, B., Knapp, M. R. J., et al (1994) Mental health residential care: classification of facilities and description of services. British Journal of Psychiatry, 169, 139-147
66. Lindström, E., Eriksson, B., Hellgren, A., et al (1995) Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia. Clinical Therapeutics, 17, 402-412.
67. McCreadie, R. G. (1992) The Nithsdale schizophrenia surveys. Social Psychiatry and Psychiatric Epidemiology, 27, 40-45.
68. _, Leese, M., Tilak-Singh, D., et al (1997) Nithsdale, Nunhead and Norwood: similarities and differences in prevalence of schizophrenia and utilisation of services in rural and urban areas. British Journal of Psychiatry, 170, 31-36.
69. McCrone, P., Beecham, J. K. & Knapp, M. R. J. (1994) Community psychiatric nurse teams: cost-effectiveness of intensive support versus generic care. British Journal of Psychiatry, 165, 218-221.
70. McGuire, T. G. (1991) Measuring the economic costs of schizophrenia. Schizophrenia Bulletin, 17, 375-387.
71. McPhillips, M. A. & Sensky, T. (1997) Coercion, adherence or collaboration? Influences on compliance with medication. In Outcome and Innovation in Psychological Treatment of Schizophrenia (ed T. Wykes). Chichester: Wiley, in press.
72. Mari, J. J. & Streiner, D. (1996) The effects of family intervention on those with schizophrenia. In Schizophrenia Module (eds C. Adams, J. Anderson & J. DeJesus Mari). Cochrane Database of Systematic Reviews. London: BMJ Publishing.
73. Marks, I. M., Connolly, J., Muijen, M., et al (1994) Home-based versus hospital-based care for people with serious mental illness. British Journal of Psychiatry, 165, 179-194.
74. Mason, P., Harrison, G., Glazebrook, C., et al (1996) The course of schizophrenia over 13 years. British Journal of Psychiatry, 169, 580-586.
75. Matheson, L. A., Cook, H. M., McKenna, P., et al (1994) Value for money care for patients with schizophrenia. British Journal of Medical Economics, 7, 25-34.
76. Melzer, D., Hale, A. S., Malik, S. J., et al (1991) Community care for patients with schizophrenia one year after hospital discharge. British Medical Journal, 303, 1023-1026.
77. Meltzer, H. Y. (1994) Cost-effectiveness of clozapine treatment. Journal of Clinical Psychiatry Monograph Series, 16, 16-17.
78. _, Cola, P., Way, L., et al (1993) Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry, 150, 1630-1638.
79. _, Gill, B., Petticrew, M., et al (1995) The Prevalence of Psychiatric Morbidity among Adults Living in Private Households. London: HMSQ.
80. _, _, _, et al (1996) The Prevalence of Psychiatric Morbidity among Adults Living in Institutions. London: HMSO.
81. Merson, S., Tvrer, P., Carlen, D., et al (1996) The cost of treatment of psychiatric emergencies: a comparison of hospital and community services. Psychological Medicine, 26, 727-734.
82. Muijen, M., Cooney, M., Strathdee, G., et al (1994) Community psychiatric nurse teams: intensive support versus generic care. British Journal of Psychiatry, 27, 165-169.
83. National Health Service Executive (1996a) Burden of Disease. Leeds: NHSE.
84. _ (1996b) 24 Hour Nursed Care for People with Severe and Enduring Mental Illness. Leeds: NHSE.
85. Nazareth, I., King, M. & Davies, S. (1995) Care of schizophrenia in general practice: the general practitioner and the patient. British Journal of General Practice, 45, 343-347.
86. Netten, A. & Dennett, J. H. (1996) Unit Costs of Health and Social Care. University of Kent at Canterbury: Personal Social Services Research Unit.
87. Perring, C., Twigg, J. & Atkin, K. (1990) Families Caring for People Diagnosed as Mentally III: The Literature Examined. London: HMSO.
88. Philo, G. & Seeker, J. (1994) What the papers say. Community Care. 24 February, 14.
89. Reid, W. H., Mason, M. & Toprac, M. (1994) Savings in hospital bed-days related to treatment with clozapine. Hospital and Community Psychiatry, 45, 261-264.
90. Revickl, D. A., Luce, B. R., Weschler, J. M., et al (1990) Cost-effectiveness of clozapine for treatment-resistant schizophrenics. Hospital and Community Psychiatry, 41, 850-854.
91. Rice, D. P., Kelman, S. & Miller, L. S. (1991) Estimates of economic costs of alcohol and drug abuse and mental illness 1985 and 1988. Public Health Reports, 106, 280-291.
92. Rouillon, F., Dansette, G. Y. & Le Floch, C. (1994) Etude de la prise en charge théraputique des schziphrènes et de son coût. L'Encèphale, 20, 303-309.
93. Rund, B. R., Moe, L. C., Sollien, T., et al (1994) The psychosis project: an efficiency study of a psychoeducational treatment for schizophrenic adolescents. Acta Psychiatrica Scandinavica, 87, 211-218.
94. Rupp, A. & Keith, S. J. (1993) The costs of schizophrenia assessing the burden. Psychiatric Clinics of North America, 16, 413-423.
95. Sayce, L. (1995) Response to violence: a framework for fair treatment. In Psychiatric Patient Violence: Risk and Response (ed. J. Crichton), pp. 127-150. London: Duckworth.
96. Schiller, M., Hargreaves, W. A., Essock, S. M., et al (1995) Clozapine's cost-effectiveness (letters). American Journal of Psychiatry, 152, 151-152.
97. Scott, J. E. & Dixon, L. B. (1995a) Assertive community treatment and case management for schizophrenia. Schizophrenia Bulletin, 21, 657-668.
98. _ & _ (1995b) Psychological interventions for schizophrenia. Schizophrenia Bulletin, 21, 621-630.
99. Sheldon, T. (1996) Problems of using modelling in the economic evaluation of health care. Health Economics, 5, 1-12.
100. Shepherd, M., Watt, D., Falloon, I., et al (1989) The natural history of schizophrenia: a five year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychological Medicine monograph, 15, 1-44.
101. Smith, K., Shah, A., Wright, K., et al (1995) The prevalence and costs of psychiatric disorders and learning disabilities. British Journal of Psychiatry, 166, 9-18.
102. Steering Committee of the Confidential Inquiry into Homicides and Suicides by Mentally Ill People (1996) Report of the Confidential Inquiry into Homicides and Suicides by Mentally III People. London: Royal College of Psychiatrists.
103. Stilwell, J. (1981) Mental health: shifting the balance of care. Public Money, 1, 31-34.
104. Szmulker, G. (1996) From family 'burden' to caregiver. Psychiatric Bulletin, 20, 449-151.
105. Tarrier, N., Lowson, K. & Barrowclough, C. (1991) Some aspects of family interventions in schizophrenia. II. Financial considerations. British Journal of Psychiatry, 159, 481-484.
106. Terkelsen, K. G. & Grosser, R. C. (1990) Estimating clozapine's cost to the nation. Hospital and Community Psychiatry, 41, 863-869.
107. Trieman, N. & Leff, J. (1994) The most difficult to place long-stay psychiatric in-patients: outcome one year after relocation. British Journal of Psychiatry, 169, 289-292.
108. Tyrer, P., Morgan, J., Van Horn, E., et al (1995) A randomised controlled study of close monitoring of vulnerable psychiatry patients. Lancet, 345, 756-759.
109. _, Evans, K., Gandhi, N., et al (1997) A randomised controlled trial of two models of care for discharged patients: no advantage of better community care with insufficient hospital beds. British Medical Journal, in press.
110. Van Putten, T. (1974) Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry, 31, 67-72.
111. Watt, D. C., Katz, K. & Shepherd, M. (1983) The natural history of schizophrenia: a five-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychological Medicine, 13, 663-670.
112. Weiden, P. J. & Olfson, M. (1995) Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419-429.
113. Weisbrod, B., Test, M. & Stein, I. (1980) An alternative to mental hospital treatment. 2. Economic cost-benefit analysis. Archives of General Psychiatry, 37, 400-405.
114. White, E. (1991) The Third Quinquennial National Community Psychiatric Nursing Survey. University of Manchester.
115. Wolff, G. (1997) Attitudes of the media and the public. In Care in the Community: Illusion or Reality? (ed. J. Leff), pp. 145-163. Chichester: Wiley.
116. Xiong, W., Phillips, M. R., Hu, X., et al (1994) Family-based intervention for schizophrenic patients in China: a randomised controlled trial. British Journal of Psychiatry, 165, 239-247.
117. Young, J. L., Zanana, H.V. & Shepter, L. (1986) Medication non-compliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatric Law, 14, 105-122.